Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$162,309,278
+$61,163,093 QoQ
Shares Held
135,322
+23.1% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#295
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
0
PutValue
$17
PutShares
2
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Federation des caisses Desjardins du Quebec holds $784,151,867 across 18 Drug Manufacturers - General names. LLY ranks #2 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,035,263 | $262,925,742 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
135,322 | $162,309,278 | |
| 3 | PFE |
Pfizer Inc
|
3,414,310 | $82,216,583 | |
| 4 | MRK |
Merck & Co., Inc.
|
514,231 | $66,078,682 | |
| 5 | ABBV |
AbbVie Inc.
|
212,267 | $53,414,866 | |
| 6 | AZN |
Astrazeneca PLC
|
209,951 | $39,810,907 | |
| 7 | SNY |
Sanofi
|
873,273 | $37,253,825 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
214,642 | $27,117,868 |
All Filings in LLY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $162,309,278 | 135,322 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $101,146,185 | 109,969 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $105,504,566 | 98,173 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $64,809,220 | 84,940 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $62,259,500 | 79,868 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $60,136,155 | 72,812 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $43,360,924 | 56,167 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $28,983,526 | 32,715 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $17 | 2 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $33,005,627 | 36,455 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $18,219,044 | 23,419 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,841,439 | 13,452 | Shares | Defined | 2024-08-15 | |
| 2023-09-30 | $8,712,248 | 16,220 | Shares | Defined | 2024-08-15 | |
| 2023-06-30 | $8,271,400 | 17,637 | Shares | Defined | 2024-08-15 | |
| 2023-03-31 | $6,266,041 | 18,246 | Shares | Defined | 2024-08-15 | |
| 2022-12-31 | $5,846,488 | 15,981 | Shares | Defined | 2024-08-15 | |
| 2022-09-30 | $5,225,012 | 16,159 | Shares | Defined | 2024-08-15 | |
| 2022-06-30 | $4,726,624 | 14,578 | Shares | Defined | 2024-08-15 | |
| 2022-03-31 | $4,141,195 | 14,461 | Shares | Defined | 2024-08-15 | |
| 2021-12-31 | $4,051,318 | 14,667 | Shares | Defined | 2024-08-30 | |
| 2021-09-30 | $3,432,478 | 14,856 | Shares | Defined | 2024-08-30 | |
| 2021-06-30 | $2,970,217 | 12,941 | Shares | Defined | 2024-08-30 | |
| 2021-03-31 | $3,635,703 | 19,461 | Shares | Defined | 2024-08-30 | |
| 2020-12-31 | $3,826,927 | 22,666 | Shares | Defined | 2024-08-30 | |
| 2020-09-30 | $1,618,598 | 10,935 | Shares | Defined | 2024-08-30 | |
| 2020-06-30 | $4,381,964 | 26,690 | Shares | Defined | 2024-08-30 | |
| 2020-03-31 | $3,282,392 | 23,662 | Shares | Defined | 2024-08-30 | |
| No filing history on record for this holder in this stock. | ||||||